Oxidized high-density lipoprotein is associated with protein-energy wasting in maintenance hemodialysis patients

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 6, 2010, Pages 1021-1028

  Honda, Hirokazu ^a   Ueda, Masashi ^b   Kojima, Shiho ^b   Mashiba, Shinichi ^b   Suzuki, Hiroki ^a   Hosaka, Nozomu ^a   Hirai, Yuki ^a   Nakamura, Mari ^a   Nagai, Hisako ^a   Kato, Noriyuki ^a   Mukai, Masanori ^a   Watanabe, Makoto ^a   Takahashi, Keiko ^c   Shishido, Kanji ^c   Akizawa, Tadao ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Ikagaku Co Ltd   (Japan)

^c Kawasaki Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN; AUTACOID; BIOLOGICAL MARKER; OXIDIZED LOW DENSITY LIPOPROTEIN; SERUM ALBUMIN;

ACCURACY; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ASSESSMENT TOOL; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OXIDATION; PREVALENCE; PROTEIN ENERGY WASTING; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; BLOOD; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; JAPAN; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; OXIDATION REDUCTION REACTION; PROSPECTIVE STUDY; PROTEIN-ENERGY MALNUTRITION; RENAL REPLACEMENT THERAPY; RISK; RISK FACTOR; STATISTICAL MODEL; TIME; UPREGULATION;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; INFLAMMATION MEDIATORS; JAPAN; LINEAR MODELS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LOGISTIC MODELS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; ODDS RATIO; OXIDATION-REDUCTION; PROSPECTIVE STUDIES; PROTEIN-ENERGY MALNUTRITION; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SERUM ALBUMIN; TIME FACTORS; UP-REGULATION;

EID: 77953314657     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06110809     Document Type: Article

References (31)

1. Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergström J: Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 15: 953-960, 2000 (Pubitemid 30410364)
2. Tabet F, Rye KA: High-density lipoproteins, inflammation and oxidative stress. Clin Sci (Lond) 116: 87-98, 2009
3. Murphy AJ, Woollard KJ, Hoang A, Mukhamedova N, Stirzaker RA, McCormick SP, Remaley AT, Sviridov D, Chin-Dusting J: High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol 28: 2071-2077, 2008
4. Florentin M, Liberopoulos EN, Wierzbicki AS, Mikhailidis DP: Multiple actions of high-density lipoprotein. Curr Opin Cardiol 23: 370-378, 2008
5. Navab M, Reddy S, Van Lenten BJ, Anantharamaiah GM, Fogelman AM: Role of dysfunctional HDL in atherosclerosis. J Lipid Res 50: S145-S149, 2008
6. Kalantar-Zadeh K, Kopple JD, Kamranpour N, Fogelman AM, Navab M: HDL-inflammatory index correlates with poor outcome in hemodialysis patients. Kidney Int 72: 1149-1156, 2007
7. K/DOQI: Clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis 41: I-IV, S1-S91, 2003
8. Yamada K, Furuya R, Takita T, Maruyama Y, Yamaguchi Y, Ohkawa S, Kumagai H: Simplified nutritional screening tools for patients on maintenance hemodialysis. Am J Clin Nutr 87: 106-113, 2008
9. K/DOQI: Clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis 35: S1-S140, 2000 (Pubitemid 30349779)
10. Daugirdas JT: Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol 4: 1205-1213, 1993
11. Shinzato T, Nakai S, Fujita Y, Takai I, Morita H, Nakane K, Maeda K: Determination of Kt/V and protein catabolic rate using pre- and postdialysis blood urea nitrogen concentrations. Nephron 67: 280-290, 1994 (Pubitemid 24177635)
12. Murphy AJ, Chin-Dusting JP, Sviridov D, Woollard KJ: The anti inflammatory effects of high density lipoproteins. Curr Med Chem 16: 667-675, 2009
13. Sampietro T, Bigazzi F, Dal Pino B, Fusaro S, Greco F, Tuoni M, Bionda A: Increased plasma C-reactive protein in familial hypoalphalipoproteinemia: A proinflammatory condition? Circulation 105: 11-14, 2002
14. Nicholls SJ, Zheng L, Hazen SL: Formation of dysfunctional high-density lipoprotein by myeloperoxidase. Trends Cardiovasc Med 15: 212-219, 2005
15. Morena M, Cristol JP, Dantoine T, Carbonneau MA, Descomps B, Canaud B: Protective effects of high-density lipoprotein against oxidative stress are impaired in haemodialysis patients. Nephrol Dial Transplant 15: 389-395, 2000 (Pubitemid 30116475)
16. Ramos LF, Shintani A, Ikizler TA, Himmelfarb J: Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. J Am Soc Nephrol 19: 593-599, 2008
17. Axelsson J, Rashid Qureshi A, Suliman ME, Honda H, Pecoits-Filho R, Heimbürger O, Lindholm B, Cederholm T, Stenvinkel P: Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 80: 1222-1229, 2004 (Pubitemid 41350682)
18. Honda H, Qureshi AR, Axelsson J, Heimburger O, Suliman ME, Barany P, Stenvinkel P, Lindholm B: Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality. Am J Clin Nutr 86: 633-638, 2007
19. Nicholls SJ, Hazen SL: Myeloperoxidase, modified lipoproteins and atherogenesis. J Lipid Res 50: S346-S351, 2008
20. Kalantar-Zadeh K, Brennan ML, Hazen SL: Serum myeloperoxidase and mortality in maintenance hemodialysis patients. Am J Kidney Dis 48: 59-68, 2006
21. Stenvinkel P, Holmberg I, Heimburger O, Diczfalusy U: A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients. Nephrol Dial Transplant 13: 2594-2600, 1998
22. Honda H, Ueda M, Kojima S, Mashiba S, Hirai Y, Hosaka N, Suzuki H, Mukai M, Watanabe M, Takahashi K, Shishido K, Akizawa T: Assessment of myeloperoxidase and oxidative alpha1-antitrypsin in patients on hemodialysis. Clin J Am Soc Nephrol 4: 142-151, 2009
23. Galli F: Protein damage and inflammation in uraemia and dialysis patients. Nephrol Dial Transplant 22[Suppl 5]: v20-v36, 2007
24. Muscaritoli M, Molfino A, Bollea MR, Rossi Fanelli F: Malnutrition and wasting in renal disease. Curr Opin Clin Nutr Metab Care 12: 378-383, 2009
25. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55: 1899-1911, 1999
26. Honda H, Qureshi AR, Heimburger O, Barany P, Wang K, Pecoits-Filho R, Stenvinkel P, Lindholm B: Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 47: 139-148, 2006
27. Ueda M, Hayase Y, Mashiba S: Establishment and evaluation of 2 monoclonal antibodies against oxidized apolipoprotein A-I (apoA-I) and its application to determine blood oxidized apoA-I levels. Clin Chim Acta 378: 105-111, 2007
28. Kontush A, Therond P, Zerrad A, Couturier M, Négre-Salvayre A, de Souza JA, Chantepie S, Chapman MJ: Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: Relevance to antiapoptotic and antioxidative activities. Arterioscler Thromb Vasc Biol 27: 1843-1849, 2007
29. Kontush A, de Faria EC, Chantepie S, Chapman MJ: Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: Relevance of enzymatic and physicochemical properties. Arterioscler Thromb Vasc Biol 24: 526-533, 2004
30. Nobecourt E, Jacqueminet S, Hansel B, Chantepie S, Grimaldi A, Chapman MJ, Kontush A: Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: Relationship to elevated oxidative stress and hyperglycaemia. Diabetologia 48: 529-538, 2005
31. Desmeules S, Arcand-Bosse JF, Bergeron J, Douville P, Agharazii M: Nonfasting non-high-density lipoprotein cholesterol is adequate for lipid management in hemodialysis patients. Am J Kidney Dis 45: 1067-1072, 2005